Suggestions
David Broecker
Chief Innovation and Collaboration Officer at Purdue Research Foundation; Founder and CEO for Zorion Medical
Professional Background
David Broecker is a distinguished business leader with extensive experience in the fields of biotechnology and medical innovation. Currently serving as the Chief Innovation and Collaboration Officer at Purdue Research Foundation, he is pivotal in spearheading strategic innovation initiatives that cater to corporate partners and key stakeholders. David's impressive career trajectory is marked by his entrepreneurial spirit and a robust track record of translating groundbreaking ideas into valuable market solutions.
Prior to his role at Purdue, David made significant contributions as the Founder and CEO of Zorion Medical, Inc., a pioneering medical device company dedicated to developing and commercializing fully absorbable technologies utilizing bio-metals. Under his leadership, Zorion Medical focuses on addressing critical health issues, particularly peripheral artery disease, with products targeting arterial dissections, congenital vascular defects in children, and AV fistulas for renal dialysis patients. This commitment to healthcare innovation underscores David's expertise in merging biotechnology with practical applications that enhance patient outcomes.
In addition, David is known for his visionary leadership at the Indiana Biosciences Research Institute, where he served as the Founding President and CEO. He played a crucial role in establishing this non-profit research organization, which is committed to advancing discovery science and applied research with a focus on diabetes, cardio-metabolic disease, and nutrition, while collaborating with the state’s top life sciences companies.
Throughout his illustrious career, David also held notable positions at Alkermes, a publicly traded biotechnology company, where he led a transformative phase by launching several new products, including the groundbreaking medication Vivitrol, aimed at treating alcohol and opiate dependence. His expertise as both an intra- and entrepreneur has enabled him to guide teams across various organizations, including multiple successful start-ups. David began his career at Eli Lilly and Company, where he spent over 15 years driving the development and commercialization of a diverse range of pharmaceutical, medical device, and diagnostic products.
Education and Achievements
David's educational background is equally impressive, equipping him with a solid foundation in science and business. He holds a Master of Science in Chemical Engineering from the prestigious Massachusetts Institute of Technology, which provides him with a strong technical acumen. Additionally, he earned a Master of Business Administration (MBA) with a focus on Finance and Marketing from the University of Chicago, allowing him to blend financial savvy with innovative marketing strategies.
David's early academic journey began at Wabash College, where he received a Bachelor of Arts degree in Chemistry, Physics, and Mathematics. This multi-disciplinary background enables him to approach problems with a analytical and multifaceted perspective.
Beyond his professional roles, David remains actively engaged in the community through his service on various boards and advisory committees. He is a board member at Zorion Medical, Inc., Apexian Pharmaceuticals, and InScope Medical. His advisory roles for AIT BioSciences and Embera exhibit his commitment to encouraging innovation and collaboration in the life sciences sector. Furthermore, as a trustee at Wabash College, David chairs the committee on Trusteeship, contributing to the governance and leadership development within the academic community.
Notable Achievements
- Pioneering Leadership in Medical Devices: As the Founder and CEO of Zorion Medical, David led the company towards developing innovative medical solutions that address significant health challenges.
- Transformational Influence at Alkermes: Under David's leadership, Alkermes experienced a major transformation with the successful launch of drugs that have had a profound impact on the treatment of dependence issues.
- Founding the Indiana Biosciences Research Institute: David's initiative to establish an independent research institute highlights his dedication to science and collaborative research, focusing on pressing health issues.
- Board Memberships and Advisory Roles: His active participation on various boards and advisory committees reinforces David's influence and commitment to fostering innovation within the biotechnology landscape.
- Academic Contributions: David's role as a trustee and chair of the committee on Trusteeship at Wabash College allows him to contribute to the next generation of leaders in science and business.
David Broecker's career is a testament to his leadership, innovation, and commitment to advancing the field of healthcare through strategic collaboration and cutting-edge research. With a unique blend of technical expertise and business acumen, he continues to inspire future generations in the life sciences industry.
tags':['biotechnology','innovation','medical devices','Purdue Research Foundation','Zorion Medical','Indiana Biosciences Research Institute','Alkermes','Eli Lilly','chemical engineering','MBA','Wabash College','breakthrough innovation'],'questions':['How did David Broecker develop his expertise in biotechnology and medical innovation?','What were the key factors that led David Broecker to establish Zorion Medical?','In what ways has David Broecker influenced the landscape of healthcare through his roles at Purdue Research Foundation and Indiana Biosciences Research Institute?','What strategies did David employ to successfully lead Alkermes during a transformative period?','How has David Broecker integrated his educational background in chemical engineering and business administration into his career in the life sciences?'],
